Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.

Merel T Stegenga Lindsey Oudijk Evert F S van Velsen Robin P Peeters Marco MediciFrederik A VerburgTessa M van GinhovenFolkert van Kemenade W. Edward Visser

Published in: The Journal of clinical endocrinology and metabolism (2024)

Classification of OTC and FTC into three subcategories as defined by the 2022 WHO Classification substantially improves discrimination between low, intermediate and high risk patients, especially for DSS and RAI-refractory disease.

Keyphrases

deep learning
machine learning
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis